France· FR:69438015
DEFERIPRONE ARROW 1000 mg, comprimé pelliculé sécable
A deferiprone product containing défériprone, registered in France by ARROW GENERIQUES. The same ATC class is registered in 16 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Deferiprone is registered in 16 of 19 countries.
Countries holding a registration under ATC V03AC02 (deferiprone), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 10 of them publish a price we can compare per daily dose
Deferiprone · ATC V03AC02
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of deferiprone costs, country by country.
Normalised to the WHO defined daily dose (5.25 g), the median price runs from $22.61 in Switzerland to $8636.08 in Italy — a ×382 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Deferiprone · price per daily dose (5.25 g)
USD · FX 28 Sept 2026
- IT Italy$8636.08
- CH Switzerland$22.61
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- DÉFÉRIPRONE
- Manufacturer
- ARROW GENERIQUES
- Country
- France (FR)
- ATC code
- V03AC02
- ATC class
- Deferiprone
- Defined daily dose
- 5.25 g, O
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip133400930155493plaquette(s) PVC polyéthylène PVDC aluminium de 50 comprimé(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
315 interactions on record for deferiprone.
Graded by severity as the source publishes them — 266 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Deferiprone · interactions on record
315 records
- 266 severe
- 49 moderate
Most severe, free to view
- FostamatinibB02BX09severe
- ProcainamideC01BA02severe
- TocainideC01BB03severe
- PropylthiouracilH03BA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Deferiprone in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenDeferipron Ebb 1000 mg Filmdragerad tablettEbb Medical AB
- CzechiaFERRIPROXChiesi Farmaceutici S.p.A., Parma
- FinlandFerriproxChiesi Farmaceutici S.p.A.
- IcelandFerriproxChiesi Farmaceutici S.p.A.*
- NetherlandsFerriprox 1000 mg, filmomhulde tablettenChiesi Farmaceutici S.p.A.
- NorwayFerriproxChiesi Farmaceutici S.p.a.
- PolandFerriproxChiesi Farmaceutici S.p.A.
- BelgiumFerriprox 1000 mgChiesi Farmaceutici
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Cyprus · Deferiprone Sapiens
- Denmark · Deferipron Orifarm
- United Kingdom (Northern Ireland) · Deferiprone Mercury Pharmaceuticals, Deferiprone Mercury Pharmaceuticals Ltd.
- Greece · Befeprox
- Iceland · Ferriprox
- Italy · Deferiprone Doc
- Liechtenstein · Ferriprox
- Norway · Ferriprox
- Portugal · Befeprox, Deferriprona Generis
- Sweden · Deferipron Evolan, Deferiprone Doc
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d144f6c4-7bee-4f9a-9b0d-490ef8111657 GET /v1/drugs/d144f6c4-7bee-4f9a-9b0d-490ef8111657?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69438015",
"date_amm": "2018-08-03",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "DÉFÉRIPRONE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé sécable",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about deferiprone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.